Literature DB >> 9479488

Cloning and characterization of a new type of mouse chemokine.

D L Rossi1, G Hardiman, N G Copeland, D J Gilbert, N Jenkins, A Zlotnik, J F Bazan.   

Abstract

We report here the identification and characterization of the mouse homologue of a human CX3C chemokine described by F. Bazan et al. (1997, Nature 385, 640-644). Termed fractalkine, this molecule constitutes a fourth or delta chemokine structural type that displays a novel CX3C sequence fingerprint. Distinct from the alpha, beta, or gamma chemokine families, the polypeptide chain of CX3C predicts a 373-amino-acid type I transmembrane glycoprotein with the chemokine domain resting on top of an extended mucin-like stalk. Comparison of the mouse and human protein chains shows a high degree of conservation in all the globular segments with the exception of the stalk portion. The striking identity of an amino acid stretch encompassing a putative juxtamembrane cleavage site suggests the evolutionary conservation of both membrane-bound and processed CX3C forms. Northern analysis reveals the presence of mouse CX3C mRNA in heart, brain, lung, kidney, skeletal muscle, and testis tissues. The mouse CX3C gene was further localized to the central region of chromosome 8 by interspecific backcross mapping; a related locus was detected on chromosome 11. The novel location of this gene from other chemokine gene clusters adds to the notion that CX3C is a fundamentally new class of chemokine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9479488     DOI: 10.1006/geno.1997.5058

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  21 in total

1.  The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood.

Authors:  Makiko Mizutani; Paula A Pino; Noah Saederup; Israel F Charo; Richard M Ransohoff; Astrid E Cardona
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

2.  Unraveling the molecular targets pertinent to junction restructuring events during spermatogenesis using the Adjudin-induced germ cell depletion model.

Authors:  Weiliang Xia; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

3.  Cloning and functional characterization of the early-lymphocyte-specific Pb99 gene.

Authors:  B P Sleckman; W N Khan; W Xu; C H Bassing; B A Malynn; N G Copeland; C G Bardon; T M Breit; L Davidson; E M Oltz; N A Jenkins; J E Berman; F W Alt
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  The microglial fractalkine receptor is not required for activity-dependent plasticity in the mouse visual system.

Authors:  Rebecca L Lowery; Marie-Eve Tremblay; Brittany E Hopkins; Ania K Majewska
Journal:  Glia       Date:  2017-08-24       Impact factor: 7.452

5.  CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.

Authors:  Dan Sunnemark; Sana Eltayeb; Maria Nilsson; Erik Wallström; Hans Lassmann; Tomas Olsson; Anna-Lena Berg; Anders Ericsson-Dahlstrand
Journal:  J Neuroinflammation       Date:  2005-07-29       Impact factor: 8.322

6.  Generation and analysis of mice lacking the chemokine fractalkine.

Authors:  D N Cook; S C Chen; L M Sullivan; D J Manfra; M T Wiekowski; D M Prosser; G Vassileva; S A Lira
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury.

Authors:  Tejbeer Kaur; Kevin K Ohlemiller; Mark E Warchol
Journal:  J Comp Neurol       Date:  2017-12-17       Impact factor: 3.215

8.  Cloning and functional characterization of the human fractalkine receptor promoter regions.

Authors:  Alexandre Garin; Philippe Pellet; Philippe Deterre; Patrice Debré; Christophe Combadière
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

9.  Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.

Authors:  Jenny A Garcia; Paula A Pino; Makiko Mizutani; Sandra M Cardona; Israel F Charo; Richard M Ransohoff; Thomas G Forsthuber; Astrid E Cardona
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

10.  Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humans.

Authors:  Mikihiko Yasuda; Tetsuhide Ito; Takamasa Oono; Ken Kawabe; Toyoma Kaku; Hisato Igarashi; Taichi Nakamura; Ryoichi Takayanagi
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.